Suppr超能文献

一项基于世界卫生组织2021年标准的综合方案,概述了精子参数与植入前遗传学检测-非整倍体检测(PGT-A)周期中体外受精(IVF)结果的关联。

A WHO 2021-based comprehensive scheme outlining sperm parameters' associations with IVF outcomes in PGT-A cycles.

作者信息

Mazzilli Rossella, Cimadomo Danilo, Innocenti Federica, Taggi Marilena, Cermisoni Greta Chiara, Ginesi Sara, Dovere Lisa, Albricci Laura, Guido Maurizio, Campitiello Maria Rosaria, Ferrero Susanna, Capalbo Antonio, Vaiarelli Alberto, Ubaldi Filippo Maria, Ferlin Alberto, Rienzi Laura, Gennarelli Gianluca

机构信息

Department of Clinical and Molecular Medicine, University "Sapienza" of Rome, Rome, Italy.

IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.

出版信息

Andrology. 2025 Oct;13(7):1745-1756. doi: 10.1111/andr.13811. Epub 2024 Nov 28.

Abstract

OBJECTIVE

To examine the association between semen parameters, assessed according to World Health Organization (WHO)-2021 criteria, and paternal body mass index (BMI) and age, with embryological and clinical outcomes in ICSI cycles involving preimplantation genetic testing for aneuploidy (PGT-A).

DESIGN

Retrospective study at a private in vitro fertilization (IVF) clinic.

SUBJECTS

3101 couples undergoing 4013 intracytoplasmic sperm injection (ICSI) + PGT-A cycles with own-oocytes (years 2013-2021).

INTERVENTION

We performed trophectoderm biopsy, and comprehensive chromosome testing to report uniform aneuploidies and vitrified-warmed euploid single-blastocyst-transfers. Regression analyses adjusted for relevant confounders were conducted to outline putative associations of semen analysis and characteristics and paternal BMI and age with all embryological/clinical outcomes.

RESULTS

Maternal age was the only significant confounding variable affecting euploidy blastocyst rate (EBR) (primary embryological outcome). When categorized, motility < 5-percentile (-2.5%, 95%CI -4.9 to -0.2%, p = 0.03), concentration plus morphology < 5-percentile (-2.7%,95%CI -4.8 to -0.6%, p = 0.01), concentration plus morphology plus motility < 5-percentile (-4.0%,95%CI -5.5 to -2.6%, p < 0.01), obstructive-azoospermia [OA] (-5.5%,95%CI -9 to -2%, p = 0.02) and non-obstructive azoospermia (NOA) (-5.8%,95%CI -10.9 to -0.6%, p = 0.03) showed significantly lower results compared to all parameters > 5-percentile. Furthermore, after adjusting for maternal age and the number of metaphase-II-oocytes inseminated, the only significant confounding variable affecting the chance of obtaining ≥ 1 live birth among completed cycles (primary clinical outcome) was basal and post sperm processing motility. When categorized, concentration plus morphology plus motility < 5-percentile (multivariable-OR: 0.73, 95%CI 0.58-0.93, p = 0.01) and OA (multivariable-OR: 0.47, 95%CI 0.24-0.92, p = 0.03) showed significantly lower chances compared to all parameters > 5-percentile. Advanced paternal age (defined as > 44 years) was associated only with lower day 5-blastocyst and Gardner's AA-grade (i.e., top quality) blastocyst rates.

CONCLUSIONS

This comprehensive analysis provides IVF professionals with useful figures to counsel infertile couples about their chances of success, taking into account the impact of semen characteristics and paternal BMI and age. These estimates are valuable for personalized decision-making about the most effective reproductive strategies to adopt, especially not underestimating male factor, by improving sperm concentration and motility whenever possible before assisted reproductive technologies.

摘要

目的

根据世界卫生组织(WHO)2021年标准评估精液参数,并研究其与父亲体重指数(BMI)和年龄之间的关联,以及这些因素对涉及胚胎植入前非整倍体基因检测(PGT-A)的卵胞浆内单精子注射(ICSI)周期的胚胎学和临床结局的影响。

设计

在一家私立体外受精(IVF)诊所进行的回顾性研究。

研究对象

3101对夫妇进行了4013个使用自身卵母细胞的卵胞浆内单精子注射(ICSI)+PGT-A周期(2013年至2021年)。

干预措施

我们进行了滋养外胚层活检和全面的染色体检测,以报告一致的非整倍体情况,并进行玻璃化冷冻-解冻后的整倍体单囊胚移植。对相关混杂因素进行调整后进行回归分析,以概述精液分析和特征以及父亲BMI和年龄与所有胚胎学/临床结局之间的假定关联。

结果

母亲年龄是影响整倍体囊胚率(EBR)(主要胚胎学结局)的唯一显著混杂变量。分类后,活力<第5百分位数(-2.5%,95%置信区间-4.9至-0.2%,p = 0.03)、浓度加形态<第5百分位数(-2.7%,95%置信区间-4.8至-0.6%,p = 0.01)、浓度加形态加活力<第5百分位数(-4.0%,95%置信区间-5.5至-2.6%,p < 0.01)、梗阻性无精子症[OA](-5.5%,95%置信区间-9至-2%,p = 0.02)和非梗阻性无精子症(NOA)(-5.8%,95%置信区间-10.9至-0.6%,p = 0.03)与所有参数>第5百分位数相比,结果显著更低。此外,在调整母亲年龄和受精的中期II期卵母细胞数量后,影响完成周期中获得≥1次活产机会(主要临床结局)唯一的显著混杂变量是基础和精子处理后的活力。分类后,浓度加形态加活力<第5百分位数(多变量OR:0.73,95%置信区间0.58 - 0.93,p = 0.01)和OA(多变量OR:0.47,95%置信区间0.24 - 0.92,p = 0.03)与所有参数>第5百分位数相比,活产机会显著更低。父亲高龄(定义为>44岁)仅与第5天囊胚和Gardner AA级(即顶级质量)囊胚率较低相关。

结论

这项综合分析为IVF专业人员提供了有用的数据,以便在考虑精液特征、父亲BMI和年龄影响的情况下,为不孕夫妇提供关于其成功机会的咨询。这些估计对于就最有效的生殖策略进行个性化决策很有价值,特别是在辅助生殖技术之前尽可能提高精子浓度和活力,从而不低估男性因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d70f/12476224/2184fba78060/ANDR-13-1745-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验